(Q34014926)

30 July 2017

1 reference

title

Chemotherapy of advanced non small cell lung cancer in the elderly: an update (English)

1 reference

30 July 2017

1 reference

Gridelli C

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Critical Reviews in Oncology Hematology

30 July 2017

published in

1 reference

30 July 2017

volume

35

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

219-225

1 reference

Lung cancer in the elderly

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Age and the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

What do we know on variables influencing clinical decision-making in elderly cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Cancer in the elderly: why so badly treated?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Carboplatin and vinorelbine in elderly patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Lonidamine plus cyclophosphamide in the treatment of adanced non-small cell lung cancer in the elderly: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Weekly vinorelbine in elderly patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Vinorelbine chemotherapy in non small cell lung cancer: experience in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

Validation of a multidimensional evaluation scale for use in elderly cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2899%2900064-5

7 January 2021

10.1016/S1040-8428(99)00064-5

Identifiers

DOI

1 reference

30 July 2017

1 reference